Sekkei Bio
Sekkei Bio is an innovation-driven biopharmaceutical company focused on developing new-age medicines to address global unmet healthcare needs. The company leverages proprietary computational platforms combining deep science, physics, and machine learning to design multi-targeted drugs for polygenic diseases. Their RNA platform advances next-generation vaccines and therapeutics, with a focus on critical healthcare challenges such as oral insulin delivery, insulin thermostability, and opioid alternatives. Sekkei Bio integrates AI with physics for in silico drug design, circular RNA technologies, and advanced formulation methods including oral peptide delivery and RNA nanoparticles. Headquartered in India, Sekkei Bio aims to become a global drug development leader by creating accessible and inclusive healthcare solutions through cutting-edge technology and strategic partnerships.
Sekkei Bio
Sekkei Bio is an innovation-driven biopharmaceutical company focused on developing new-age medicines to address global unmet healthcare needs. The company leverages proprietary computational platforms combining deep science, physics, and machine learning to design multi-targeted drugs for polygenic diseases. Their RNA platform advances next-generation vaccines and therapeutics, with a focus on critical healthcare challenges such as oral insulin delivery, insulin thermostability, and opioid alternatives. Sekkei Bio integrates AI with physics for in silico drug design, circular RNA technologies, and advanced formulation methods including oral peptide delivery and RNA nanoparticles. Headquartered in India, Sekkei Bio aims to become a global drug development leader by creating accessible and inclusive healthcare solutions through cutting-edge technology and strategic partnerships.